Items where authors include "McNamara, S."

Article

Love-Koh, J. orcid.org/0000-0001-9009-5346, Schneider, P., McNamara, S. orcid.org/0000-0003-1082-118X et al. (2 more authors) (2023) Decomposition of Quality-Adjusted Life Expectancy Inequalities by Mortality and Health-Related Quality of Life Dimensions. PharmacoEconomics, 41 (7). pp. 831-841. ISSN 1170-7690

Schneider, P., Love-Koh, J., McNamara, S. orcid.org/0000-0003-1082-118X et al. (2 more authors) (2022) Socioeconomic inequalities in HRQoL in England: an age-sex stratified analysis. Health and Quality of Life Outcomes, 20. 121. ISSN 1477-7525

McNamara, S., Tsuchiya, A. orcid.org/0000-0003-4245-5399 and Holmes, J. orcid.org/0000-0001-9283-2151 (2021) Does the UK-public's aversion to inequalities in health differ by group-labelling and health-gain type? A choice-experiment. Social Science & Medicine, 269. 113573.

Stevely, A.K. orcid.org/0000-0002-5637-5245, Holmes, J., McNamara, S. et al. (1 more author) (2020) Drinking contexts and their association with acute alcohol‐related harm : a systematic review of event‐level studies on adults' drinking occasions. Drug and Alcohol Review, 39 (4). pp. 309-320. ISSN 0959-5236

McNamara, S., Holmes, J., Stevely, A.K. et al. (1 more author) (2020) How averse are the UK general-public to inequalities in health between socioeconomic groups? A systematic review. The European Journal of Health Economics, 21 (2). pp. 275-285. ISSN 1618-7598

Lee, D., Amadi, A., Sabater, J. et al. (9 more authors) (2019) Can we accurately predict cost effectiveness without access to overall survival data? The case study of nivolumab in combination with ipilimumab for the treatment of patients with advanced melanoma in England. PharmacoEconomics - Open, 3 (1). pp. 43-54. ISSN 2509-4262